a public good project by the
Synthesis
Company
of California

© 2026

Rhett P. Ketterling | doi.page

0 works0 citations0 h-index

Rhett P. Ketterling

Mayo Clinic in Arizona(US)Mayo Clinic in Florida(US)

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments

Most-Cited Works

→ Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia(2012)1,935 cited
→ Anthracycline Dose Intensification in Acute Myeloid Leukemia(2009)902 cited
→ Mutations and prognosis in primary myelofibrosis(2013)741 cited
→ Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis(2014)716 cited
→ CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons(2014)536 cited
→ MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis(2017)521 cited

→ ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes(2014)

460 cited

→ T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)(2009)410 cited

→ CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy(2003)395 cited

→ Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases(2004)386 cited